Three-dimensional imaging has fundamentally transformed the landscape of complex surgical interventions, and nowhere is this more evident than in the planning and execution of islet cell transplants for patients with type 1 diabetes. By converting flat, two-dimensional scans into rotatable, multi-layered anatomical models, surgeons gain an unprecedented understanding of the pancreas, its vascular supply, and the liver implantation site. This deep spatial awareness directly translates into safer procedures, better graft survival, and more predictable long-term outcomes. For transplant teams aiming to restore endogenous insulin production, 3D imaging is no longer a luxury—it is an essential pillar of modern surgical planning.

Understanding Islet Cell Transplants: A Primer

Islet cell transplantation is a cellular replacement therapy designed to free selected patients with type 1 diabetes from the burden of exogenous insulin dependence and the constant risk of severe hypoglycemic episodes. The procedure involves isolating the islets of Langerhans—micro-organs containing insulin-producing beta cells—from a donor pancreas and infusing them into the recipient's portal vein. Once lodged in the liver sinusoids, these cells engraft and begin secreting insulin in response to blood glucose levels, effectively mimicking the native pancreatic response. Although the procedure is not a cure in the sense of being lifelong without immunosuppression, for many patients it dramatically improves glycemic control and quality of life.

The clinical pathway is demanding: patients must undergo extensive pre-transplant evaluation, receive potent immunosuppressive therapy, and often require more than one donor infusion to achieve insulin independence. Success depends not only on the quantity and quality of transplanted islets but also on the precise, atraumatic delivery to the liver and the subsequent viability of the engrafted cells. This is where advanced imaging steps into the spotlight.

Why Conventional Imaging Falls Short

Standard cross-sectional imaging modalities such as computed tomography (CT) and magnetic resonance imaging (MRI) provide excellent tissue contrast and can identify the pancreas and its surrounding vasculature. However, these modalities present the data as a stack of axial slices that the surgeon must mentally reconstruct into a three-dimensional picture. For an organ as variable in shape, position, and vascular arrangement as the pancreas, this cognitive process introduces risk. Subtle aberrations—a replaced right hepatic artery, a tortuous splenic vein, a shortened mesenteric root—can be missed in a slice-by-slice review, leading to intraoperative surprises that may compromise safety or graft delivery.

Furthermore, conventional 2D images do not allow for volumetric analysis, simulation of the infusion catheter trajectory, or visualisation of how the islet-depositing catheter relates to the portal vein bifurcations. Without a 3D model, the surgeon essentially operates with a map that lacks elevation, depth, and real-world spatial relationships. 3D imaging bridges this gap entirely.

How 3D Imaging Works in the Transplant Context

The creation of a 3D model begins with high-resolution CT or MRI data. For islet cell transplant planning, a contrast-enhanced CT scan of the abdomen is typically performed with thin slice thickness (1 mm or less) during arterial and portal venous phases. This dataset is then exported to dedicated post-processing software—often using segmentation algorithms that automatically or semi-automatically outline the pancreas, liver, portal vein, splenic vessels, and superior mesenteric vessels. The result is a color-coded, interactive 3D reconstruction that can be manipulated on a screen, viewed from any angle, and even exported for 3D printing or augmented reality (AR) headsets.

Key structures routinely segmented include:

  • Donor pancreas anatomy (if a whole pancreas or segment is imaged prior to islet isolation)
  • Recipient liver volume and portal vein branching pattern
  • Hepatic artery variability (e.g., replaced or accessory arteries that must be avoided during catheter placement)
  • Splenic and mesenteric vein confluence (the entry point for the portal vein)
  • Potential collateral vessels or varices that might alter flow dynamics

Once the model is built, surgeons can measure distances, calculate angles, and simulate catheter insertion paths. Some advanced platforms even allow for computational flow dynamics (CFD) to model how the infusion of islets in a suspension medium will distribute within the portal vein branches—information that directly predicts the risk of portal hypertension or embolisation.

Volumetry and Graft Sizing

Accurate volumetry is a critical output of 3D imaging. The surgeon can measure the liver volume and the portal vein diameter at the intended puncture site, ensuring that the catheter size and infusion volume are appropriate for the patient. Overestimation can lead to portal vein thrombosis; underestimation can result in suboptimal islet distribution. 3D models also allow the team to determine the target zone of infusion—typically a segmental portal branch that provides a large vascular bed for islet engraftment without causing excessive hepatic injury.

Preoperative Planning: From Model to Operative Strategy

The true power of 3D imaging emerges during the planning phase, where it directly informs the surgical approach. Islet cell transplantation is performed via a percutaneous transhepatic approach under radiographic guidance, or in some centers, via a mini-laparotomy. In either case, the operator must know the exact trajectory to avoid major vessels, the gallbladder, biliary ducts, and the colon. A 3D model visualises these relationships in a way that a CT report simply cannot.

Identifying High-Risk Anatomical Variants

Anatomical variants are common in the portal venous system. For example, a trifurcation of the portal vein (rather than the typical bifurcation) may require careful selection of the branch to cannulate. A replaced left hepatic artery arising from the left gastric artery crosses the caudate lobe and can be injured during needle passage. Surgeons using 3D models can pre-mark the safe window for needle entry and catheter advancement, significantly reducing the risk of hemorrhage or bile leak.

Simulating Catheter Placement

Many planning software tools now include a catheter simulation feature. The surgeon can input the intended gauge, length, and curve of the catheter and then “see” how it will align with the portal anatomy. This helps in choosing the correct equipment—for instance, a curved sheath for a steep angle of entry—and reduces the number of needle passes, which in turn lessens bleeding risk and parenchymal damage to the liver.

Predicting Portal Pressure Changes

One of the most serious intraoperative complications during islet infusion is a sudden rise in portal pressure due to islet lodging and micro-embolisation. While real-time pressure monitoring is standard, 3D modelling can predict which patients are at highest risk. Models that incorporate the volume and diameter of the distal portal branches can flag a “low-capacity” system that may not tolerate a full infusion. In such cases, the transplant team can plan to split the infusion across multiple sessions or use a smaller catheter in a larger branch.

Reducing Complications: A Data-Driven Approach

The central promise of 3D imaging in islet cell transplants is complication reduction. When surgeons have a complete spatial understanding of the anatomy, the most common adverse events become far less common.

  • Bleeding: By visualizing the entire hepatic parenchymal tract and the course of the portal vein and hepatic arteries, the operator avoids arterial punctures during the transhepatic approach. Studies have shown a reduction in postprocedural hemoperitoneum when 3D guidance is used.
  • Portal vein thrombosis: 3D volumetry allows the team to choose an infusion volume that does not exceed the portal tree’s capacity, thus lowering the risk of clot formation.
  • Bile duct injury: The 3D model clearly delineates the biliary tree (especially when combined with MRCP data), guiding the needle track away from the biliary system.
  • Inadvertent intra-abdominal infusion: Knowing the exact depth and angle to reach the portal vein eliminates the chance of the catheter passing through the liver capsule into the peritoneal cavity.
  • Islet embolization to extrahepatic sites: By steering the catheter into a targeted branch, the surgeon ensures the islets are delivered to the liver parenchyma rather than shunted into the systemic circulation.

These reductions are not theoretical. A 2023 retrospective analysis comparing conventional CT planning versus 3D-model-based planning for islet cell transplants found a 37% lower rate of major adverse events (bleeding, thrombosis, need for reintervention) in the 3D-guided group, even after adjusting for patient demographics and BMI. The models also allowed for shorter procedure times—a direct benefit for both patient and resource utilization.

Postoperative Imaging: Monitoring Graft Engagement and Survival

After the transplant, 3D imaging continues to provide value. While early postoperative assessment is often performed with duplex ultrasound or non-contrast MRI (to avoid nephrotoxic contrast agents in immunosuppressed patients), advanced 3D techniques can be used to monitor the fate of the transplanted islets.

Assessing Islet Distribution and Engraftment

Using iron-labeled islets combined with 3D MRI acquisition, researchers have been able to visualize the distribution and density of islets across the liver parenchyma. This technique—called “MRI/magnetic particle imaging (MPI) fusion”—generates a 3D map showing where the islets lodged and whether they remain viable over weeks. If a region shows signal decay, it may indicate islet death or migration, prompting the team to adjust immunosuppression or consider a booster infusion. While still investigational, these methods represent the cutting edge of post-transplant graft surveillance.

Detecting Portal Hypertension and Steatosis

Serial 3D volumetry can also track changes in liver volume and portal vein diameter, which are indirect signs of portal hypertension. If the liver enlarges or the portal vein dilates beyond normal parameters, the team can intervene early with anticoagulation or dilation of the portal system. Additionally, 3D analyses of fat content (via multi‑echo MRI) can detect hepatic steatosis that may compromise islet function—an underappreciated complication of high-dose immunosuppression.

Long-Term Surveillance for Malignancy

Immunosuppressed patients have an elevated risk of lymphoma and other malignancies. 3D imaging studies that include the entire abdomen provide a comprehensive baseline for future comparison, making it easier to detect new masses earlier than with traditional 2D screening protocols.

Challenges and Limitations of 3D Imaging in Islet Transplantation

Despite its promise, 3D imaging is not yet universal in islet transplant programs. Several barriers remain:

  • Cost and Access: High-end post-processing software and radiologist or surgeon time to segment models are expensive. Smaller transplant centers may not have the resources or volume to justify the investment.
  • Processing Time: Creating a detailed 3D model can take 30–60 minutes of manual or semi-automated work. In urgent transplant situations—for instance, a same-day deceased donor islet isolation—the delay may be unacceptable. Automating the segmentations with deep learning is an active area of research.
  • User Training: Not all surgeons are comfortable manipulating 3D models or interpreting volumetric data. Integrating this technology into routine practice requires dedicated training and a shift in workflow.
  • Radiation Dose: CT-based 3D models require a multiphase scan that exposes the patient to ionizing radiation and intravenous contrast. For patients with repeated evaluations (e.g., those awaiting multiple donor infusions), cumulative radiation can be a concern. MRI-based 3D models avoid radiation but are less detailed in depicting small vessels.
  • Software Standardisation: Different vendors use different segmentation algorithms, measurement conventions, and visualization tools. This lack of standardisation makes it difficult to compare data across centers and to conduct multi-center trials.

Nevertheless, the trend is clear: as computing power increases and software becomes more automated and affordable, 3D imaging will become the standard of care for islet cell transplant planning.

Future Directions: Augmented Reality, AI, and Bioprinting

The next frontier in 3D imaging for islet cell transplants involves real-time integration into the operating room. Augmented reality (AR) overlays allow the surgeon to see the 3D model projected onto the patient’s abdomen or even into the eyepiece of a percutaneous needle guide system. Early prototypes have shown that AR can reduce needle passes by up to 40% in liver procedures, and specific platforms are being adapted for the transhepatic approach used in islet infusion. The surgeon looks at the patient’s skin and sees the portal vein, the catheter path, and the target branch superimposed in three dimensions, adjusting the needle angle in real time.

Artificial intelligence (AI) is poised to automate the segmentation and planning process entirely. Deep convolutional neural networks can now segment the pancreas, portal vein, and liver from CT scans in under 60 seconds with accuracy rivaling manual segmentation. These algorithms can also flag high-risk anatomical variants and suggest optimal catheter entry points. In the near future, an AI engine could receive the raw CT data and output a fully annotated 3D model with a recommended surgical plan—all before the patient leaves the scanner.

Machine learning models are also being trained to predict post-transplant outcomes based on 3D model features. For example, the ratio of portal vein branch volume to islet mass may be a powerful predictor of success. By mining large datasets of previous transplants, these models can provide a personalized success probability and help tailor the immunosuppression regimen or the number of islets to infuse.

Finally, 3D bioprinting of islet-containing scaffolds may one day replace the liver as the transplantation site. Researchers are creating vascularized 3D-printed constructs that house islets in a protected microenvironment. Imaging techniques used to design these scaffolds are precisely the same 3D modelling methods described here—a direct synergy between imaging and tissue engineering that promises to eliminate the need for donor islets altogether.

Conclusion

Three-dimensional imaging has evolved from a niche visualization tool into an indispensable component of islet cell transplant planning and follow-up. By providing precise anatomical roadmaps, enabling predictive simulations, and reducing perioperative complications, 3D models directly improve patient outcomes. While challenges related to cost, time, and standardisation persist, the rapid development of artificial intelligence and augmented reality will soon make 3D imaging accessible to every center performing these life-changing procedures. For patients with brittle type 1 diabetes, the combination of islet cell transplantation and 3D imaging represents a powerful synergy—one that moves us closer to reliable, durable glycemic control without the daily burden of insulin injections.